Amgen, Inc. AMGN shares are trading higher on Thursday, after the company and Adaptive announced they will partner to develop a coronavirus therapeutic.
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Amgen's shares were trading up 5.4% to $208.49 at time of publication. The stock has a 52-week high of $244.99 and a 52-week low of $166.30.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in